Dorzolamide cyclodextrin nanoparticle suspension eye drops and Trusopt in rabbit.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Moya-Ortega, Maria D
Asgrímsdóttir, Gudrun Marta
Agnarsson, Bjarni A
Lund, Sigrún H
MetadataShow full item record
CitationJ Ocul Pharmacol Ther. 2014, 30 (6):464-7
AbstractDorzolamide nanoparticle γ-cyclodextrin eye drops may prolong the effect of dorzolamide on intraocular pressure. We test whether the nanoparticle drops have an irritating or toxic effect on the eye in an in vivo rabbit model.
Eighteen pigmented rabbits were divided into 4 groups receiving dorzolamide nanoparticle γ-cyclodextrin eye drops×1/day or×2/day, Trusopt® (dorzolamide HCl)×3/day, and untreated controls that received no drops. The rabbits received treatment for 1 month. After sacrifice, 33 eyes and 25 Harderian glands were evaluated for histopathology in a masked way.
Mild inflammation was seen in 19/31 eyes and 13/23 Harderian glands. The difference in inflammation (n=eyes/n=glands)between the γ-cyclodextrin nanoparticle eye drops×1/day (n=5/5),×2/day (n=5/3), Trusopt (n=7/4), or untreated control (n=2/0) groups was nonsignificant in both eyes and glands (P=0.87 and P=0.92) Acute inflammation was seen in 1 Harderian gland that received γ-cyclodextrin nanoparticle eye drops×2/day. The difference in conjunctival injection between the groups was nonsignificant (P=0.30).
Dorzolamide γ-cyclodextrin nanoparticle eye drops are no more locally toxic or irritating to the eye than Trusopt.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
- γ-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man.
- Authors: Gudmundsdottir BS, Petursdottir D, Asgrimsdottir GM, Gottfredsdottir MS, Hardarson SH, Jóhannesson G, Kurkov SV, Jansook P, Loftsson T, Stefánsson E
- Issue date: 2014 Feb
- Kinetics of γ-cyclodextrin nanoparticle suspension eye drops in tear fluid.
- Authors: Jóhannesson G, Moya-Ortega MD, Ásgrímsdóttir GM, Lund SH, Thorsteinsdóttir M, Loftsson T, Stefánsson E
- Issue date: 2014 Sep
- Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
- Authors: Jansook P, Stefánsson E, Thorsteinsdóttir M, Sigurdsson BB, Kristjánsdóttir SS, Bas JF, Sigurdsson HH, Loftsson T
- Issue date: 2010 Oct
- Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.
- Authors: Park CG, Kim YK, Kim SN, Lee SH, Huh BK, Park MA, Won H, Park KH, Choy YB
- Issue date: 2017 Apr 30
- Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration.
- Authors: Sigurdsson HH, Stefánsson E, Gudmundsdóttir E, Eysteinsson T, Thorsteinsdóttir M, Loftsson T
- Issue date: 2005 Jan 20